{"id":15940,"date":"2012-12-07T10:30:00","date_gmt":"2012-12-07T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/janssen-consente-uso-del-generico-di-darunavir-nei-pvs\/"},"modified":"2012-12-07T10:30:00","modified_gmt":"2012-12-07T09:30:00","slug":"janssen-consente-uso-del-generico-di-darunavir-nei-pvs","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/janssen-consente-uso-del-generico-di-darunavir-nei-pvs\/","title":{"rendered":"Janssen allows use of darunavir generic in developing countries"},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"font-size: large;\">The Company announced that it is withdrawing its patent rights to the antiretroviral drug darunavir, <strong>provided that the corresponding generic drug gives all the <\/strong><u><strong>guarantees of safety and efficacy<\/strong><\/u><\/span><\/p>\n<p style=\"text-align: center;\"><strong><span style=\"font-size: xx-large;\"><a href=\"http:\/\/www.pharmastar.it\/index.html?cat=7&amp;id=9789\" target=\"_blank\" rel=\"noopener\">Janssen allows use of darunavir generic in developing countries<\/a> <\/span><\/strong><\/p>\n<p> &nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>L&#8217;Azienda ha annunciato di rinunciare a far valere i propri diritti brevettuali dell&rsquo;antiretrovirale darunavir, a condizione che il farmaco generico corrispondente dia tutte le garanzie di sicurezza ed efficacia Janssen consente uso del generico di darunavir nei PVS &nbsp;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15940","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15940"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15940\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}